Subclassification of the Syndrome of Inappropriate ADH Secretion
NCT ID: NCT01341665
Last Updated: 2011-04-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2008-03-31
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
These types will be characterized by measurement of AVP and copeptin while performing an osmotic stimulation with infusion of hypertonic saline.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tolvaptan Versus Fluid Restriction in SIADH
NCT04119206
Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine
NCT00298753
Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus
NCT00004363
Use of Copeptin in Diabetes Insipidus
NCT01940614
Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children
NCT06604975
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hyponatremia \< 132 mmol/L
* SIADH
Exclusion Criteria
* cerebral metastases
* serum sodium \> 132mmol/L
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Wuerzburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Endocrinology and Diabetes, University of Wuerzburg
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bruno Allolio, MD
Role: STUDY_CHAIR
Ethical commitee
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Wuerzburg
Würzburg, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5/08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.